Attenuation by cyclic phosphatidic acid of peritoneal metastasis of azoxymethane‐induced intestinal cancers in Wistar rats

• Published in: International journal of cancer 2004-06, Vol.110 (2), p.188-193
• Main Authors: Ishihara, Ryu, Tatsuta, Masaharu, Iishi, Hiroyasu, Baba, Miyako, Uedo, Noriya, Higashino, Koji, Mukai, Mutsuko, Ishiguro, Shingo, Kobayashi, Susumu, Murakami‐Murofushi, Kimiko
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - drug therapy; Adenocarcinoma - pathology; Animals; Antineoplastic agents; Azoxymethane; Biological and medical sciences; Chemotherapy; Cyclic AMP - biosynthesis; cyclic phosphatidic acid; intestinal cancer; Intestinal Neoplasms - chemically induced; Intestinal Neoplasms - drug therapy; Intestinal Neoplasms - pathology; Lysophospholipids - pharmacology; Lysophospholipids - therapeutic use; Male; Medical sciences; metastasis; Neoplasm Invasiveness; Peritoneal Neoplasms - prevention & control; Peritoneal Neoplasms - secondary; Pharmacology. Drug treatments; Rats; Rats, Wistar; RhoA; rhoA GTP-Binding Protein - antagonists & inhibitors
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/ijc.20069

The effect of cyclic phosphatidic acid, a unique analogue of lysophosphatidic acid, on the induction of bombesin‐enhanced peritoneal metastases from intestinal adenocarcinomas induced by azoxymethane was investigated in male Wistar rats. Rats were given 10 weekly injections of azoxymethane (7.4 mg/kg body weight, s.c.) and of bombesin (40 μg/kg body weight, s.c.) every other day from the start of the experiment, and from week 16, they received injections of cyclic phosphatidic acid (3 or 6 mg/kg body weight, s.c.) every other day until the end of the experiment in week 45. Cyclic phosphatidic acid at both dosages significantly decreased the incidence of bombesin‐enhanced cancer metastases to the peritoneum but had little or no effect on the location, histologic type, depth of involvement or infiltrating growth patterns of the tumors. Cyclic phosphatidic acid at either dose decreased significantly the incidence of lymphatic vessel invasion of adenocarcinomas and the activity of RhoA protein in the tumors, both of which were enhanced by bombesin. Our findings indicate that cyclic phosphatidic acid inhibits cancer metastasis through inhibition of RhoA protein activation. © 2004 Wiley‐Liss, Inc.